Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy

Published:2003-06 Issue:3-4 Volume:14 Page:337-348
ISSN:1359-6101
Container-title:Cytokine & Growth Factor Reviews
language:en
Short-container-title:Cytokine & Growth Factor Reviews

Author:

Almasan Alexandru,Ashkenazi Avi

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Endocrinology, Diabetes and Metabolism

Reference126 articles.

1. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family;Pitti;J. Biol. Chem.,1996

2. Identification and characterization of a new member of the TNF family that induces apoptosis;Wiley;Immunity,1995

3. The receptor for the cytotoxic ligand TRAIL;Pan;Science,1997

4. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors;Sheridan;Science,1997

5. An antagonist decoy receptor and a death domain-containing receptor for TRAIL;Pan;Science,1997

Cited by 489 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microglia either promote or restrain TRAIL-mediated excitotoxicity caused by Aβ1−42 oligomers;Journal of Neuroinflammation;2024-09-01

2. Combining the constitutive TRAIL-secreting induced neural stem cell therapy with the novel anti-cancer drug TR-107 in glioblastoma;Molecular Therapy: Oncology;2024-09

3. TRAIL receptor agonist TLY012 in combination with PD-1 inhibition promotes tumor regression in an immune-competent mouse model of pancreatic ductal adenocarcinoma;2024-08-30

4. Neuroprotective effects of anti-TRAIL-ICG nanoagent and its multimodal imaging evaluation in cerebral ischemia-reperfusion injury;Materials Today Bio;2024-06

5. Comparison of 177Lu-octreotate and 177Lu-octreotide for treatment in human neuroblastoma-bearing mice;Heliyon;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3